Clinical Trials Browser

Phase 2 × Lymphoma, Large-Cell, Anaplastic × Bevacizumab × Clear all

NCT00217425 2023-06-18

Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms

Phase 2 Completed

46 enrolled 7 charts

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00016094 2013-01-29

S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma

Phase 2 Completed

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell